SDC1 and central nervous system cancer: SDC1 in plEVs could discriminate between GBM and low-grade glioma with a sensitivity of 71%, and specificity of 91%.The findings support the concept of circulating plEVs as a tool for non-invasive diagnosis and monitoring of gliomas.